Dale L. Ludwig is Chief Scientific Officer at Actinium Pharmaceuticals, Inc. (ATNM). They have made 1 open-market trade across 1 company since 2018, most recently 2018-11-19.
CIK 0001727406
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $5K since 2018, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ATNM | 10,000 | $11K |
Shares reported on the most recent Form 4, priced at the 2018-11-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ATNM | BUY | 2018-11-19 | 2018-11-20 | $0.45 | $5K | +34.9% | -2.4% | +36.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.